Theriva Biologics Inc (TOVX)
1.28
+0.02
(+1.59%)
USD |
NYAM |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2010 | -1.26K% |
| September 30, 2010 | -252.8% |
| June 30, 2010 | 44.64% |
| March 31, 2010 | -1.81K% |
| December 31, 2009 | -2.14K% |
| September 30, 2009 | -1.23K% |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | |
| March 31, 2003 | -1.17K% |
| December 31, 2002 | |
| September 30, 2002 | |
| June 30, 2002 | -31.77K% |
| March 31, 2002 |
| Date | Value |
|---|---|
| December 31, 2001 | |
| September 30, 2001 | |
| June 30, 2001 | -328.8% |
| March 31, 2001 | |
| December 31, 2000 | -746.8% |
| September 30, 2000 | -2.86K% |
| June 30, 2000 | -1.11K% |
| March 31, 2000 | -1.20K% |
| December 31, 1999 | -6.66K% |
| September 30, 1999 | -1.50K% |
| June 30, 1999 | -2.14K% |
| March 31, 1999 | -4.47K% |
| December 31, 1998 | |
| September 30, 1998 | -2.10K% |
| June 30, 1998 | -3.32K% |
| March 31, 1998 | -2.30K% |
| December 31, 1997 | -375.0% |
| September 30, 1997 | -1.90K% |
| June 30, 1997 | -3.40K% |
| March 31, 1997 | -2.70K% |
| December 31, 1996 | |
| September 30, 1996 | -266.7% |
| June 30, 1996 | -1.70K% |
| March 31, 1996 | -1.70K% |
| December 31, 1995 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 18.95% |
| Pro-Dex Inc | 16.56% |
| BioCardia Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |